HIGHBRIDGE CAPITAL MANAGEMENT LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 183 filers reported holding IMMUNOGEN INC in Q3 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2017$835,000
-42.0%
130,363
-30.7%
0.02%
-31.8%
Q3 2017$1,439,000
+384.5%
188,200
+440.8%
0.02%
+340.0%
Q1 2016$297,000
-83.9%
34,800
-72.9%
0.01%
-78.3%
Q2 2015$1,845,000
+142.4%
128,255
+99.8%
0.02%
+155.6%
Q2 2014$761,00064,1900.01%
Other shareholders
IMMUNOGEN INC shareholders Q3 2017
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders